However, statistical analysis showed the significant association between TMB and mutations in EGFR, TP53, LRP1B, LRP2, and CDKN2A, suggesting potential biomarkers for the prognosis of Chinese lung cancer patients. Here, LRP1B is linked to lung carcinoma.